About The Company - hldpharma

page-template,page-template-full_width,page-template-full_width-php,page,page-id-15284,theme-bridge,bridge-core-1.0.4,woocommerce-no-js,ajax_fade,page_not_loaded,,qode-title-hidden,columns-4,qode-product-single-tabs-on-bottom,qode-theme-ver-18.0.8,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,wpb-js-composer js-comp-ver-7.9,vc_responsive

About Us

HLD Pharmaceuticals is a launching in the industry for providing best quality medicines to the needers. Our company was emerged in the year 2016 at Asansol in West Bengal, India. We supply, export and trade a wide range of products that includes Medical Equipment, tablet, syp, soft gelatine cap etc… The entire range of products is marketed by us from the reliable and G.M.P. certified vendors of the industry. They use high grade material and latest technology under the hygienic environment for manufacturing these products. We get consistent appreciation from our prestigious and reputed clientele due to the effectiveness, world class quality and accurate composition of our products.

Our company is currently headed by a group of young ambitious professionals who have been looking for opportunities for expansion and diversification. Mr. Partha Pratim Hazra is amongst them, knowledgeable and experienced. His precious contribution and hard work takes our company to the top position of the industry.

The name ‘HLD’ is came from Health, Life & Discovery.

CEO’s Message

weak-up and run for future.

At the same time an etiological indications are shifting towards the prevalence of lifestyle diseases over acute illness indicating a departure from age old dynamics in disease and treatment.

On the other hand there has been a paradigm shift in the use of innovative drugs to that of low-cost API drugs after the economic recession, thereby causing a positive impact on the overall growth of the API market. As per the industry observers India and China will be the major API hub in next decade. In order to avail ourselves with this change we have mulled well to integrate further into Active Pharmaceutical Ingredient (API) and High Potency Active Pharmaceutical Ingredient (HPAPI).

Demand of Drug Intermediates was always there and increasing further with the emergent of India as a major API player. So our final goal is a versatile Drug Intermediate production facility.

All the production facilities will be eco friendly and shall be built with a strong sense of social commitment.

For a considerable period we have produced a number of path breaking drugs production techniques not only for the benefit of our country but also a large section of suffering mankind of South East Asia. It also introduced a number of improvised techniques to produce industrial chemicals at much cheaper cost which liberated many an end user from the vagaries of finding the right producer.

For decades the Indian Pharmaceutical industry is a free flowing river of prosperity by the rich water watersheds of contribution from numberless personalities and institutions. It becomes the chief driving force of today’s international recognition of reverence. We at HLD Pharmaceuticals shall dreem our toil be accomplished if our endeavor can add few more droplets into that stream.

Our Mission

“Health in antiquity was as important as it is today.” The company’s mission is to provide the medical profession with a complete armament against diseases caused by Environmental pollution andLifestyle transformation.

Our Vision

The company views health care entrepreneurship as finding a solution to modern health care challenges and making the fruits of modern medical research available to the suffering humanity in a friendly environment.

Manufacturing Facilities

The Company envisages of an integrated manufacturing process for this project. To start with we shall establish an international class fixed dosage pharmaceutical manufacturing facility. That facility shall house production unit for tablets, capsules, oral liquid, Ointment and Parenteral for both the Beta-Lactam and non Beta-Lactum group.

In the second phase of integration we shall go for multiline Active Pharmaceutical Ingredient (API) plant with versatile process capacity. This type of industry has almost no presence in the Eastern India. Once commissioned it will not only help our plant in the input provision but also other Pharmaceutical houses in this region shall be hugely benefitted.

In the third phase we are envisaging to put plant for essential and import substitute Drug Intermediates. This will complete the backward integration of our production plan.